LUX HEALTH TECH ACQUISITION - COM CL A (LUXA)

CUSIP: 55068A100

Q2 2021 13F Holders as of 30 Jun 2021

Type / Class
Equity / COM CL A
Total 13F shares
20,221,516
Share change
+3,513,488
Total reported value
$199,993,000
Put/Call ratio
79%
Price per share
$9.89
Number of holders
54
Value change
+$34,574,335
Number of buys
31
Number of sells
15

Quarterly Holders Quick Answers

What is CUSIP 55068A100?
CUSIP 55068A100 identifies LUXA - LUX HEALTH TECH ACQUISITION - COM CL A in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of LUX HEALTH TECH ACQUISITION - COM CL A (LUXA) as of Q2 2021

As of 30 Jun 2021, LUX HEALTH TECH ACQUISITION - COM CL A (LUXA) was held by 54 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 20,221,516 shares. The largest 10 holders included Empyrean Capital Partners, LP, Wolfswood Holdings, LLC, Senator Investment Group LP, Balyasny Asset Management LLC, MILLENNIUM MANAGEMENT LLC, MYDA Advisors LLC, GLAZER CAPITAL, LLC, Weiss Asset Management LP, Governors Lane LP, and Castle Creek Arbitrage, LLC. This page lists 54 institutional shareholders reporting positions in this security for the Q2 2021 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.